Navigation Links
Zacks Investment Ideas feature highlights: PharMerica, First Defiance Financial, American Railcar Industries and Big 5 Sporting Goods
Date:4/15/2013

CHICAGO, April 15, 2013 /PRNewswire/ -- Today, Zacks Investment Ideas feature highlights Features: PharMerica Corp (NYSE: PMC), First Defiance Financial Corp. (Nasdaq: FDEF), American Railcar Industries (Nasdaq: ARII) and Big 5 Sporting Goods Corporation (Nasdaq: BGFV).

(Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO)

4 Cheap Small-Cap Stocks

It's well known that stocks as an asset class have delivered strong returns over the long run. But if you dig a little deeper into the numbers, you notice that some corners of the stock market have performed better than others.

In particular, small cap stocks have outperformed large cap stocks over time.

According to research from investment management firm Royce & Associates, from 1926-2011, small cap stocks delivered average annual returns of 11.3% compared to 9.5% for the larger S&P 500.

Not impressed? Consider the growth of $10,000 over that period. With the S&P, you would've wound up with $23.4 million. Not too shabby. But with small caps, you would have amassed a remarkable $100.4 million!

And if you zoom in a little further, you'll see that small cap value stocks outperform small cap growth stocks. According to Royce & Associates, from 1979-2011 the Russell 2000 Value index returned an average of 13.0% per year, which is a whopping 400 basis points more than the Russell 2000 Growth index average of 9.0%.

Hidden Gems

The outperformance of value stocks shouldn't be a surprise to most. Investors are often too optimistic about the growth prospects of glamour stocks and end up paying too much for a future that doesn't materialize. Similarly, they tend to be too pessimistic about the future for value stocks, allowing astute investors to "buy low" and wait for business to turn around.

But why do small caps tend to outperform their larger peers?

There are a couple of theories for their strong performance:

  • Less Efficiency: Small caps stocks are more likely to be mispriced by the market because they tend to have less analyst coverage and are often overlooked by large institutional investors.
  • Higher Risk Premium: Smaller companies are riskier than larger companies and usually exhibit more volatility in their prices, so investors require a larger required return to compensate for this risk.

In either case, if you're willing to live with a little more risk, then you might be able to generate stronger stock market returns with small cap value stocks.

4 Small Cap Value Stocks

Using the Research Wizard screening program, I searched for stocks with a market cap between $150 million and $1 billion and low valuation multiples. I also added criteria that a stock needs to have a Zacks Rank of 1 (Strong Buy). Why? Because this indicates rising earnings estimates, and stocks with strong earnings momentum are much more likely to outperform the market than stocks with declining earnings estimates.

Below are 4 small cap value stocks with strong earnings momentum from the screen:

1. PharMerica Corp (NYSE: PMC)

PharMerica provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals, and other long-term alternative care settings. It has a market cap of $424 million. Shares of Pharmerica trade at a very attractive 9.8x 12-month forward earnings and 7.9x cash flow. This is in spite of the fact that the company has delivered 10 straight positive earnings surprises. It is a Zacks Rank #1 (Strong Buy) stock.

2. First Defiance Financial Corp. (Nasdaq: FDEF) is a unitary thrift holding company focused on traditional banking and property and casualty, life and group health insurance products through its three subsidiaries: First Federal Bank of the Midwest, First Insurance Group of the Midwest and First Defiance Risk Management Inc. With a market capitalization of just $228 million, it's not a stock on many investors' radars. But with a forward P/E ratio of just 10.8 and a price to book ratio of only 0.8, perhaps it should be. First Defiance has also seen a big jump in earnings estimates since it delivered a big positive earnings surprise on January 28.

3. American Railcar Industries (Nasdaq: ARII)

American Railcar manufactures hopper and tank railcars and has a market cap of $911 million. The company reported record profit margins and earnings for 2012, and it also reported an average positive earnings surprise of 42% over the last 4 quarters. It is a Zacks Rank #1 (Strong Buy) stock. Despite this, shares trade at a relatively modest 11.0x 12-month forward earnings and 10.3x cash flow.

4. Big 5 Sporting Goods Corporation (Nasdaq: BGFV)

Big Five Sporting Goods is a sporting goods retailer with 414 stores in 12 states in the western U.S. It has a market cap of $331 million. The company has delivered three consecutive positive earnings surprises and has seen a sharp increase in earnings estimates for both 2013 and 2014 over the last several months. It is a Zacks Rank #1 (Strong Buy) stock. Shares trade at a very reasonable 13.8x forward earnings and 9.8x cash flow.

The Bottom Line

If you're looking to stack the odds of market-beating returns in your favor, then you need to explore small cap value stocks with strong earnings momentum. These four all fit that criteria.

 

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Len Zacks . The company continually processes stock reports issued by 3,000 analysts from 150 brokerage firms.  It monitors more than 200,000 earnings estimates, looking for changes.

 

Then when changes are discovered, they're applied to help assign more than 4,400 stocks into five Zacks Rank categories:  #1 Strong Buy, #2 Buy, #3 Hold, #4 Sell, and #5 Strong Sell. This proprietary stock picking system; the Zacks Rank, continues to outperform the market by nearly a 3 to 1 margin.  The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter Profit from the Pros.  In short, it's your steady flow of profitable ideas GUARANTEED to be worth your time.  Get your free subscription to Profit from the Pros at:  http://at.zacks.com/?id=7298

 

Follow us on Twitter:  http://twitter.com/ZacksResearch

 

Join us on Facebook:  http://www.facebook.com/ZacksInvestmentResearch

 

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

 

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

 

Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com

 

 

 


'/>"/>
SOURCE Zacks Investment Research, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Zacks Industry Outlook Highlights: Eli Lilly, Novo Nordisk, Biogen, Amgen and Osiris Therapeutics
2. Zacks Bull and Bear of the Day Highlights: Fortune Brands Home & Security, Wal-Mart Stores, Regeneron Pharmaceuticals, Bayer and Array Biopharma
3. Zacks Bull and Bear of the Day Highlights: Smithfield Foods, Logitech International, Sanofi, Isis Pharmaceuticals and Aegerion Pharmaceuticals
4. Zacks Sell List Highlights: J.C. Penney, Spirit AeroSystems Holdings, The New York Times and Jazz Pharmaceuticals
5. Zacks Bull and Bear of the Day Highlights: Discover Financial Services, POSCO, AstraZeneca, Bayer and Takeda Pharmaceutical
6. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
7. Medical Equipment Monthly Deals Analysis: February 2013 - M&A and Investment Trends
8. Medical Equipment Annual Deals Analysis: M&A and Investments Trends - 2012
9. MDHI Receives Strategic Investment to Continue Strong Growth - Moves into Positive Operating Cash Flow for March 2013 Quarter
10. Frost & Sullivan: Government Support Vital to Encourage Venture Capital Investments in the North American Healthcare Industry
11. Saladax Biomedical Receives $22.4 Million Strategic Equity Investment From Shanghai Fosun Pharmaceutical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... -- Glycotope GmbH, a clinical-stage immuno-oncology company ... of Dr. Alfredo Zurlo as Chief Medical ... many years clinical experience and a proven track record ... was at Mologen AG where he was Chief Medical ... Zurlo held various positions at F Hoffmann La Roche ...
(Date:4/28/2016)... 2016 Research and Markets has ... Products Market 2016-2020" report to their offering. ... The global plastic surgery products market is expected ... period 2016-2020. , ,The growing adoption of laser in ... of the market. Lasers are used to treat a ...
(Date:4/28/2016)... YORK , April 28, 2016 ... online consumer insights on healthcare, announced today that it ... their report Cool Vendor in Life Sciences, 2016, ... April 15, 2016.  The report focuses on life-science- oriented ... gain insight from patients and doctors, confirm medication ingestion, ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Robert Mondavi, one of the ... smiles. Cosmetic dentistry is a fast-growing field as more patients are discovering the many ... learn more about the options currently available to them and which ones might work ...
(Date:4/29/2016)... ... , ... Reltok Nasal Products proudly announces that Boston Medical Products, Inc., a ... throat specialty, has added the KOTLER NASAL AIRWAY™ to its diverse product line. , ... patented safety device secured by nasal surgeons onto the floor of the nasal passages, ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... growth round of funding led by Eastside Partners, with participation from existing investor ... growing customer base and accelerate its technology and product roadmap. , ...
(Date:4/29/2016)... ... April 29, 2016 , ... Regenerative Medicine Solutions ... to Work employee satisfaction survey, earning them second place for Tampa’s Best Places to ... employees. , “This is a great accomplishment for our team,” says RMS Human ...
(Date:4/29/2016)... ... April 29, 2016 , ... The infertility specialists at HRC Fertility/Orange County (HRC/OC) ... Daniel A. Potter -- are proud of the recent release of their 2014 in ... SART published the latest verified data for 375 U.S. member clinics. *Preliminary ...
Breaking Medicine News(10 mins):